Targeting gonadotropin receptor genes: reproductive biology, aging, and related health implications

Natalia Danilovich1, M Ram Sairam

  • 1Molecular Reproduction Research Laboratory, Clinical Research Institute of Montréal, Canada.

Endocrine
|July 22, 2005
PubMed

Insights

Deleting FSH and LH receptors in mice impacts gonadal development and fertility differently in males and females. These mice offer models for studying hormone replacement therapy and age-dependent phenotypes.

Area of Science:

  • Reproductive Biology
  • Endocrinology
  • Genetics

Background:

  • Follicle-stimulating hormone (FSH) and luteinizing hormone (LH) are critical for reproductive functions.
  • Gonadotropin receptors mediate the effects of FSH and LH.
  • Understanding the roles of these receptors is key to reproductive health.

Purpose of the Study:

  • To review the effects of FSH receptor (FSH-R) and LH receptor (LH-R) deletion in mice.
  • To analyze the impact on gonadal development, sexual maturity, and fertility.
  • To explore potential applications in therapeutic strategies.

Main Methods:

  • Analysis of existing research on FSH-R and LH-R knockout mouse models.
  • Phenotypic characterization of male and female mice lacking functional FSH-R or LH-R.
  • Evaluation of reproductive, hormonal, and other physiological parameters.

Main Results:

  • Gonadal differentiation occurs without gonadotropin receptors, but development is impaired.
  • Female knockouts exhibit infertility, underdeveloped gonads, and hormonal imbalances.
  • Male fertility is reduced (FSH-R KO) or absent (LH-R KO) with associated testicular defects.
  • Both sexes show phenotypes like obesity, bone deficiency, brain changes, and reproductive tract tumors.
  • Hormonal profiles include estrogen and testosterone level alterations.

Conclusions:

  • FSH and LH receptors are essential for normal gonadal development and function.
  • These knockout models are valuable for studying reproductive disorders and hormone replacement therapy.
  • FSH-R heterozygous females may serve as models for age-related reproductive studies.

Related Concept Videos

Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Gonadal and Placental Hormones01:24

Gonadal and Placental Hormones

The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...